Pfizer Inc (PFE) Stock Price, Quote & News

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 212 733 2323

Website: www.pfizer.com

Address:

66 Hudson Boulevard East, New York, United States

DuragVince13 May. 23 at 10:35 AM

$MRNA $PFE damn. They really killed the rowdy one smfh

0 · Reply

Micheal_Pothead May. 22 at 8:00 PM

$PFE miserable

0 · Reply

Micheal_Pothead May. 22 at 7:37 PM

$PFE it’s only slightly less exciting than watching paint dry

1 · Reply

_Crim_Jamer_ May. 22 at 7:28 PM

$PFE wall street hitting the sell button here like...

0 · Reply

MrPeanutEsquire May. 22 at 6:41 PM

$PFE Lilly on track to close this month up two Pfizers. Incredible

2 · Reply

mdotcda13 May. 22 at 6:30 PM

$PFE mentioned by Trump when trump was sworn in

1 · Reply

LSX69Chevelle May. 22 at 5:48 PM

$PFE 👀

0 · Reply

morgangj May. 22 at 5:09 PM

$PFE

0 · Reply

pasuny May. 22 at 4:16 PM

$PFE Unbelievable... No hope...

0 · Reply

Linhrx May. 22 at 3:05 PM

$PFE let’s accumulate some🤑✅🦞🍻

1 · Reply

Moderately bullish activity in Pfizer with shares up 0.41%

May 20, 2026, 9:00 AM EDT - 3 days ago

Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer

2026-05-20T09:30:10.000Z - 3 days ago

Pfizer announces pneumococcal conjugate vaccine candidate data

May 20, 2026, 5:08 AM EDT - 3 days ago

Pfizer's pneumococcal shot shows stronger immune response in mid-stage trial

May 20, 2026, 5:05 AM EDT - 3 days ago

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

2026-05-18T17:01:06.000Z - 4 days ago

PFE, NVO, LLY: Pharma Stocks Drop as TrumpRx Set for ‘Dramatic Expansion’

AZN LLY NVO SNY

May 18, 2026, 8:00 AM EDT - 5 days ago

Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026

May 14, 2026, 2:22 PM EDT - 8 days ago

Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch

DGX MO CL

2026-05-14T17:29:38.000Z - 8 days ago

Pfizer price target raised to $26 from $25 at Wolfe Research

2026-05-13T19:23:39.000Z - 9 days ago

Mixed options sentiment in Pfizer with shares up 0.48%

2026-05-13T19:22:15.000Z - 9 days ago

Arvinas price target raised to $16 from $14 at BofA

ARVN RIGL

2026-05-13T11:10:14.000Z - 10 days ago

Pfizer says EC grants marketing approval to expand indication for Hympavzi

May 13, 2026, 6:45 AM EDT - 10 days ago

European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

2026-05-13T07:12:25.000Z - 10 days ago

Pfizer (PFE) Delivered a Solid Q1. The Patent Cliff Keeps Me Bearish

LLY NVO

2026-05-12T17:45:03.000Z - 10 days ago

H.C. Wainwright says Pfizer handing off Veppanu to Rigel ‘makes strategic sense’

ARVN RIGL

2026-05-12T16:35:26.000Z - 11 days ago

Arvinas, Pfizer enter license pact with Rigel Pharmaceuticals for Veppanu

ARVN RIGL

2026-05-12T13:02:04.000Z - 11 days ago

Rigel Pharmaceuticals enters license agreement with Arvinas, Pfizer

ARVN RIGL

May 12, 2026, 8:00 AM EDT - 11 days ago

Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug

ARVN RIGL

May 12, 2026, 7:00 AM EDT - 11 days ago

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

ARVN

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

May 5, 2026, 4:09 PM EDT - 17 days ago

Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

Pfizer secures deals to keep heart drug free of generic rivals until 2031

Apr 28, 2026, 10:41 AM EDT - 25 days ago

U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Apr 16, 2026, 1:01 PM EDT - 5 weeks ago

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

VALN

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Mar 23, 2026, 9:36 AM EDT - 2 months ago

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Mar 12, 2026, 8:00 AM EDT - 2 months ago

0 · Reply

Micheal_Pothead May. 22 at 8:00 PM

$PFE miserable

0 · Reply

Micheal_Pothead May. 22 at 7:37 PM

$PFE it’s only slightly less exciting than watching paint dry

1 · Reply

_Crim_Jamer_ May. 22 at 7:28 PM

$PFE wall street hitting the sell button here like...

0 · Reply

MrPeanutEsquire May. 22 at 6:41 PM

$PFE Lilly on track to close this month up two Pfizers. Incredible

2 · Reply

mdotcda13 May. 22 at 6:30 PM

$PFE mentioned by Trump when trump was sworn in

1 · Reply

LSX69Chevelle May. 22 at 5:48 PM

$PFE 👀

0 · Reply

morgangj May. 22 at 5:09 PM

$PFE

0 · Reply

pasuny May. 22 at 4:16 PM

$PFE Unbelievable... No hope...

0 · Reply

Linhrx May. 22 at 3:05 PM

$PFE let’s accumulate some🤑✅🦞🍻

1 · Reply

Mrdrifter May. 22 at 3:02 PM

$PFE sitting right on support — next week should be boom 📈

1 · Reply

MrPeanutEsquire May. 22 at 3:00 PM

$PFE I cant wait to not own this stock someday. It is my dream

2 · Reply

dust6431 May. 22 at 2:53 PM

$PFE Absolutely hated, becaues they turned down Elliots offer ........

0 · Reply

PFElinepfrenzy1990 May. 22 at 2:50 PM

$PFE - We’re dragging $NVDA down, sorry Nvidia

2 · Reply

doubleuptwice May. 22 at 2:16 PM

$PFE the constant rejection above 26.09

1 · Reply

Micheal_Pothead May. 22 at 2:07 PM

$PFE guess it’s a 26.00 pin?

1 · Reply

pasuny May. 22 at 1:57 PM

$PFE Stupid CEO I hate his accent. Why can he sound like Sundar Pichai? Sundar Pichai's accent is the sexiest accent I've ever heard! We need an Indian CEO!!!!

1 · Reply

Micheal_Pothead May. 22 at 1:52 PM

$PFE POS..

1 · Reply

pasuny May. 22 at 1:51 PM

$PFE Miserable worthless pathetic disgusting filthy company.

1 · Reply

nimii May. 22 at 1:50 PM

$PFE 😡

0 · Reply

Micheal_Pothead May. 22 at 1:44 PM

$PFE LLY is up another 2% lol

0 · Reply

Market Cap	147.90B
Revenue (ttm)	62.58B
Net Income (ttm)	7.77B
EPS (ttm)	N/A
PE Ratio	8.43
Forward PE	8.64
Profit Margin	12.42%
Debt to Equity Ratio	0.71

Volume	22,320,000
Avg Vol	36,867,918
Day's Range	N/A - N/A
Shares Out	5.70B
Stochastic %K	74%
Beta	0.35
Analysts	Sell
Price Target	$29.28